<DOC>
	<DOCNO>NCT02845453</DOCNO>
	<brief_summary>The purpose study determine whether quetiapine effective treatment youth co-occurring substance use disorder bipolar disorder .</brief_summary>
	<brief_title>Treatment With Quetiapine Youth With Substance Use Disorders Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Male female age 15 24 Meet DSM5 criterion substance use disorder Substance use ≥ 14 day past 28 day ( i.e . use ≥ 50 % day past 28 day ) If subject restrict setting/care ( e.g . detox residential treatment ) ≤ 2 week , use ≥ 50 % day outside restrict setting ( e.g . 7 day substance use 14 day unrestricted set ) Meet DSM5 criterion bipolar disorder YMRS ≥ 20 Stable treated outpatient level care Current opioid methamphetamine use disorder Pregnant breastfeeding Placement restrict set ( e.g . detox residential treatment ) ≥ 2 week past 28 day Unwilling unable use effective birth control Unwilling unable sign release information treatment program provide behavioral treatment For participant &gt; 17 years—unable unwilling identify emergency contact Medical psychiatric condition likely make participation unsafe judge clinical investigator History QTc &gt; 450 arrhythmia , family history malignant arrhythmia , sudden death AST ALT great three time normal BMI ≥ 95th percentile Poor command English language Current treatment quetiapine , allergy quetiapine</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>youth</keyword>
	<keyword>adolescent</keyword>
	<keyword>young adult</keyword>
	<keyword>substance use disorder</keyword>
	<keyword>bipolar disorder</keyword>
	<keyword>quetiapine</keyword>
</DOC>